Showing results (2481-2490 of 4,783) with videos related to
Sort By:
Pageof 479
Drug Discovery Today|May 4, 2020
Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right targetDaniele BaniDrug Discovery Today|April 24, 2020
Vaporization, bioactive formulations and a marine natural product: different perspectives on antiviralsThomas J Manning, Jenu Thomas-Richardson, Matthew Cowan, et al.Drug Discovery Today|May 20, 2021
Innovation in breakthrough drugs and vaccines: Development risk, patient impact, and valueAndrew E Prigodich, Shuntai Wang, Patrick Verhoest, et al.Drug Discovery Today|August 14, 2021
The forced swim test has poor accuracy for identifying novel antidepressantsEmily R Trunnell, Constança CarvalhoDrug Discovery Today|August 14, 2021
Modulation of serine/threonine-protein phosphatase 1 (PP1) complexes: A promising approach in cancer treatmentBárbara Matos, John Howl, Carmen Jerónimo, et al.Drug Discovery Today|August 17, 2021
Evaluating the performance of drug-repurposing technologiesJames Schuler, Zackary Falls, William Mangione, et al.Drug Discovery Today|August 6, 2021
Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding roadBashkim Kadriu, Laura Musazzi, Jenessa N Johnston, et al.Drug Discovery Today|August 26, 2021
Histamine 2 receptors in cardiovascular biology: A friend for the heartSherin Saheera, Ajay Godwin Potnuri, Ashrith Guha, et al.Drug Discovery Today|June 23, 2020
Degraders early developability assessment: face-to-face with molecular propertiesGiuseppe Ermondi, Maura Vallaro, Giulia CaronDrug Discovery Today|June 23, 2020
Exportin 1 inhibition as antiviral therapyMd Hafiz Uddin, Jeffrey A Zonder, Asfar S AzmiPageof 479